Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefixime for Early Syphilis in Non-pregnant Women
NCT03752112Phase 2Unknown
- Sponsor
- World Health Organization
- Start
- Nov 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cefixime in syphilis (2 arms), sponsored by World Health Organization. Primary endpoint: Quantitative RPR titer change at 6 months. Status: unknown.
02
Drugs
cefixime
03
Conditions
syphilis
Beyond the preview
Go deeper on NCT03752112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752112.